Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS)

Historical Holders from Q1 2021 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Symbol
BVS on Nasdaq
Shares outstanding
66,342,236
Price per share
$7.44
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
49,169,132
Holdings value
$328,943,000
% of all portfolios
0%
Share change
+693,030
Value change
+$4,728,324
Average buys %
+0%
Average sells %
-0%
Number of holders
133
Price from insider filings
$7.57
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 8% +18% $39,289,464 +$6,918,992 5,280,842 +21% Nantahala Capital Management, LLC 30 Jun 2025
As of 30 Sep 2025, Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) has 133 institutional shareholders filing 13F forms. They hold 49,169,132 shares of 66,342,236 outstanding shares (74%) .

Top 25 institutional shareholders own 67% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Essex Woodlands Management, Inc. 20% 13,021,324 0% 28% $87,112,658
Juniper Investment Company, LLC 10% 6,939,357 0% 18% $46,424,298
Nantahala Capital Management, LLC 8.8% 5,810,662 +10% 2.4% $38,873,329
BlackRock, Inc. 4.6% 3,068,948 -2.2% 0% $20,531,261
VANGUARD GROUP INC 4.4% 2,924,788 +4.4% 0% $19,566,832
ROYCE & ASSOCIATES LP 1.9% 1,262,976 +16% 0.08% $8,449,309
GEODE CAPITAL MANAGEMENT, LLC 1.7% 1,100,850 +4.4% 0% $7,366,011
AMERICAN CENTURY COMPANIES INC 1.6% 1,091,088 -2.9% 0% $7,299,379
Kent Lake PR LLC 1.5% 1,000,200 +186% 3.4% $6,691,338
STATE STREET CORP 1.3% 876,434 -0.87% 0% $5,863,343
RENAISSANCE TECHNOLOGIES LLC 1.2% 811,200 +2.6% 0.01% $5,426,928
DIMENSIONAL FUND ADVISORS LP 1.1% 743,431 +11% 0% $4,973,217
Divisadero Street Capital Management, LP 1% 695,517 -36% 0.22% $4,653,009
OBERWEIS ASSET MANAGEMENT INC/ 0.91% 601,714 0% 0.15% $4,025,467
Qube Research & Technologies Ltd 0.79% 525,103 +25% 0% $3,512,939
KENNEDY CAPITAL MANAGEMENT LLC 0.7% 461,579 +220% 0.07% $3,087,964
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.67% 447,203 +6.5% 0% $2,991,788
Eversept Partners, LP 0.65% 433,933 0.22% $2,903,012
GOLDMAN SACHS GROUP INC 0.59% 392,400 +187% 0% $2,625,156
AQR CAPITAL MANAGEMENT LLC 0.59% 390,227 +0.25% 0% $2,610,619
NORTHERN TRUST CORP 0.57% 377,382 -4.3% 0% $2,524,687
PANAGORA ASSET MANAGEMENT INC 0.49% 325,199 -0.5% 0.01% $2,175,581
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.46% 305,000 +30% 0.03% $2,040,450
Knights of Columbus Asset Advisors LLC 0.45% 299,760 +3.1% 0.11% $2,005,394
FMR LLC 0.44% 292,534 -3% 0% $1,957,049

Institutional Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 13,456 $99,821 +$85,387 $7.44 4
2025 Q3 49,169,132 $328,943,000 +$4,728,324 $6.69 133
2025 Q2 48,385,322 $320,311,775 +$5,188,595 $6.62 132
2025 Q1 46,840,874 $428,591,001 +$16,740,556 $9.15 143
2024 Q4 45,507,685 $477,889,871 +$661,315 $10.50 149
2024 Q3 44,941,761 $537,109,991 +$77,622,971 $11.95 138
2024 Q2 38,578,679 $221,832,142 +$26,597,890 $5.75 100
2024 Q1 34,228,194 $177,979,045 +$3,474,885 $5.20 84
2023 Q4 23,200 $122,264 +$122,264 $5.27 1
2023 Q3 32,998,084 $108,893,302 +$3,326,710 $3.30 67
2023 Q2 31,892,169 $92,169,980 +$3,237,198 $2.89 64
2023 Q1 31,249,963 $33,441,187 -$4,739,700 $1.07 69
2022 Q4 31,360,069 $81,847,512 -$22,356,597 $2.61 82
2022 Q3 33,556,956 $234,892,893 +$8,020,961 $7.00 87
2022 Q2 32,587,086 $222,243,964 +$3,917,059 $6.82 89
2022 Q1 31,686,396 $446,704,897 +$7,166,136 $14.10 99
2021 Q4 31,090,453 $450,388,332 +$88,644,112 $14.49 92
2021 Q3 24,846,535 $351,818,300 +$55,488,627 $14.16 67
2021 Q2 20,703,928 $364,388,973 -$15,202,541 $17.60 52
2021 Q1 21,873,216 $334,224,000 +$334,223,567 $15.28 45